<!DOCTYPE html>
<html>
<head>
  <meta charset="UTF-8">
  <title>OPRA Trial Appraisal Quiz (50 Questions) - Plausible Distractors</title>
  <style>
    body { font-family: Arial, sans-serif; margin: 20px; }
    h1 { color: #333; }
    .question-container { margin-bottom: 20px; }
    .options { list-style-type: none; padding: 0; }
    .options li { margin-bottom: 10px; }
    .feedback { font-weight: bold; margin-top: 10px; }
    .correct { color: green; }
    .incorrect { color: red; }
    .hidden { display: none; }
    button { padding: 10px 20px; margin-top: 10px; }
  </style>
</head>
<body>
  <h1>OPRA Trial Appraisal Quiz</h1>
  <div id="quiz">
    <div id="question-container" class="question-container"></div>
    <button id="submit-btn">Submit Answer</button>
    <div id="feedback" class="feedback"></div>
    <button id="next-btn" class="hidden">Next Question</button>
  </div>
  <div id="result" class="hidden">
    <h2>Your Score: <span id="score"></span> out of 50</h2>
  </div>

  <script>
    // Array of 50 questions with more plausible distractors.
    const questions = [
      {
        question: "1. What is the primary objective of the OPRA trial?",
        options: [
          "To assess if a watch‐and‐wait strategy after TNT yields DFS similar to historical controls.",
          "To determine if surgery can be completely omitted.",
          "To compare different surgical resection techniques."
        ],
        correct: 0,
        explanation: "The paper’s aim is to test if organ preservation via watch‐and‐wait maintains DFS. It states: “Organ preservation is achievable in half of the patients with rectal cancer treated with total neoadjuvant therapy, without detriment in survival compared with historical controls.”"
      },
      {
        question: "2. What hypothesis did the OPRA trial test?",
        options: [
          "That TNT with watch‐and‐wait maintains DFS while preserving the rectum.",
          "That more chemotherapy cycles improve overall survival.",
          "That radiation alone can cure rectal cancer."
        ],
        correct: 0,
        explanation: "The trial hypothesized that TNT with selective watch‐and‐wait can preserve the rectum without compromising DFS, as noted: “...without an apparent detriment in survival compared with historical controls.”"
      },
      {
        question: "3. Which patient group was enrolled?",
        options: [
          "Patients with stage I rectal cancer.",
          "Patients with stage II or III rectal adenocarcinoma.",
          "Patients with metastatic rectal cancer."
        ],
        correct: 1,
        explanation: "Eligibility was for stage II or III disease. The paper states: “Eligible patients were older than 18 years and had clinical stage II or III rectal adenocarcinoma.”"
      },
      {
        question: "4. What was a key inclusion criterion?",
        options: [
          "Age over 18 with stage II/III rectal adenocarcinoma confirmed by biopsy and imaging.",
          "Any patient presenting with rectal pain.",
          "Patients with previous pelvic radiation."
        ],
        correct: 0,
        explanation: "Inclusion required confirmed stage II/III rectal adenocarcinoma. The paper notes: “Eligible patients were older than 18 years and had clinical stage II or III rectal adenocarcinoma.”"
      },
      {
        question: "5. Why was a nonsurgical approach explored?",
        options: [
          "To reduce morbidity from surgery and preserve the rectum.",
          "To completely eliminate chemotherapy.",
          "To shorten the treatment duration significantly."
        ],
        correct: 0,
        explanation: "The rationale was to avoid surgical morbidity. The paper explains there is “a strong incentive to explore nonsurgical treatment options.”"
      },
      {
        question: "6. In this trial, what does 'organ preservation' refer to?",
        options: [
          "Avoiding TME in patients who respond well to TNT.",
          "Preserving all organs regardless of treatment.",
          "Using a less invasive surgical technique."
        ],
        correct: 0,
        explanation: "‘Organ preservation’ means sparing the rectum if a complete or near‐complete response is achieved. The paper states: “Organ preservation is achievable in half of the patients…”"
      },
      {
        question: "7. What trial design was used?",
        options: [
          "A prospective, randomized, multicenter phase II trial.",
          "A retrospective study.",
          "A single-center observational pilot."
        ],
        correct: 0,
        explanation: "The study was a prospective, randomized, multicenter phase II trial, as described in the paper."
      },
      {
        question: "8. How was randomization performed?",
        options: [
          "Using computer-generated block randomization stratified by institution.",
          "By drawing lots manually.",
          "Patients chose their treatment arm."
        ],
        correct: 0,
        explanation: "Randomization was computer-generated and stratified. The paper states: “Random assignment was stratified per institution and accomplished by the method of random permuted block.”"
      },
      {
        question: "9. Which element minimizes selection bias?",
        options: [
          "Stratified block randomization.",
          "An open-label design.",
          "Patient self-selection."
        ],
        correct: 0,
        explanation: "Stratified block randomization minimizes bias. The paper indicates this method was used to ensure fair assignment."
      },
      {
        question: "10. What is the purpose of a phase II trial here?",
        options: [
          "To evaluate preliminary efficacy and safety before a larger phase III trial.",
          "To confirm definitive efficacy for approval.",
          "To solely assess treatment toxicity."
        ],
        correct: 0,
        explanation: "Phase II trials test preliminary efficacy and safety. The paper was “designed as two stand-alone phase II studies.”"
      },
      {
        question: "11. How was allocation concealment achieved?",
        options: [
          "Through a centralized database with block randomization.",
          "By publishing assignments openly.",
          "No allocation concealment was used."
        ],
        correct: 0,
        explanation: "Allocation concealment was maintained using a central database and block randomization, as described in the paper."
      },
      {
        question: "12. Why is power analysis important?",
        options: [
          "It ensures enough participants to detect a meaningful DFS difference.",
          "It helps decide the study’s overall budget.",
          "It is used only for side-effect assessment."
        ],
        correct: 0,
        explanation: "Power analysis ensures adequate sample size. The paper required “101 patients evaluable for the primary end point per group to have 85% power.”"
      },
      {
        question: "13. Which two regimens were compared?",
        options: [
          "INCT-CRT (chemo then CRT) versus CRT-CNCT (CRT then consolidation chemo).",
          "Chemoradiation versus surgery alone.",
          "Different radiation dosages."
        ],
        correct: 0,
        explanation: "The two regimens compared were INCT-CRT and CRT-CNCT, as specified in the paper."
      },
      {
        question: "14. Which arm offered a watch-and-wait option?",
        options: [
          "Both arms, based on tumor response.",
          "Only the INCT-CRT arm.",
          "Only the CRT-CNCT arm."
        ],
        correct: 0,
        explanation: "Both arms allowed a watch-and-wait strategy based on tumor response, according to the paper."
      },
      {
        question: "15. Why was chemotherapy administered before surgery?",
        options: [
          "To treat micrometastases and improve treatment compliance.",
          "To entirely replace the need for surgery.",
          "To significantly shorten the treatment course."
        ],
        correct: 0,
        explanation: "Chemotherapy was given to treat micrometastases and improve compliance, as noted in the paper."
      },
      {
        question: "16. What does the 'comparator' refer to?",
        options: [
          "The standard treatment regimen used for comparison.",
          "A placebo control group.",
          "A group receiving no treatment."
        ],
        correct: 0,
        explanation: "The comparator is the standard approach against which the experimental method is measured, per the paper."
      },
      {
        question: "17. What treatment details were critical in the intervention?",
        options: [
          "The dosage, frequency, and duration of chemo and radiotherapy.",
          "Only the type of chemotherapy used.",
          "The manufacturer of the drugs."
        ],
        correct: 0,
        explanation: "Detailed treatment protocols are crucial. The paper specifies “4 months of infusional fluorouracil-leucovorin-oxaliplatin or capecitabine-oxaliplatin.”"
      },
      {
        question: "18. How did the study ensure treatments were comparable?",
        options: [
          "By using similar chemo and radiotherapy protocols in both groups.",
          "By giving one group extra doses.",
          "By allowing patients to choose adjustments."
        ],
        correct: 0,
        explanation: "Both groups were treated similarly, as the paper notes the proportions receiving FOLFOX or CAPEOX were similar in both arms."
      },
      {
        question: "19. What was the primary outcome measure?",
        options: [
          "3-year disease-free survival (DFS).",
          "Overall survival at 5 years.",
          "Tumor response rate immediately post-treatment."
        ],
        correct: 0,
        explanation: "The primary outcome was 3-year DFS. The paper defines DFS as “the interval from random assignment to the first occurrence of ...”"
      },
      {
        question: "20. Which secondary outcome was assessed?",
        options: [
          "TME-free survival (organ preservation rate).",
          "Immediate tumor shrinkage.",
          "Patient-reported quality of life only."
        ],
        correct: 0,
        explanation: "TME-free survival was the secondary endpoint. The paper clearly states: “the secondary end point was TME-free survival.”"
      },
      {
        question: "21. How is DFS defined in the study?",
        options: [
          "Time from randomization to the first event (recurrence or death).",
          "Time from surgery to local recurrence.",
          "Overall survival regardless of events."
        ],
        correct: 0,
        explanation: "DFS is defined as time from randomization to an event. The paper states: “the interval from random assignment to the first occurrence of locoregional failure, distant metastasis, a new invasive colorectal primary, or death from any cause.”"
      },
      {
        question: "22. Which outcome assesses local disease control?",
        options: [
          "Local recurrence-free survival.",
          "Progression-free survival overall.",
          "Overall survival rates."
        ],
        correct: 0,
        explanation: "Local recurrence-free survival measures local control. The paper reports Kaplan–Meier estimates for this endpoint."
      },
      {
        question: "23. Why measure both primary and secondary outcomes?",
        options: [
          "To provide a comprehensive evaluation of efficacy and safety.",
          "To unnecessarily complicate the study design.",
          "Because one measure is usually unreliable."
        ],
        correct: 0,
        explanation: "Measuring both offers a full picture, as the paper evaluates DFS along with organ preservation."
      },
      {
        question: "24. Why is reliability of outcome assessment crucial?",
        options: [
          "It ensures the results are accurate and reproducible.",
          "It mainly influences the study budget.",
          "It is only important for statistical significance."
        ],
        correct: 0,
        explanation: "Accurate and reproducible assessments are key. The paper advises to “evaluate the validity and reliability of measurement tools used.”"
      },
      {
        question: "25. What statistical method was used for survival analysis?",
        options: [
          "Cox regression with Kaplan–Meier curves.",
          "Simple linear regression.",
          "A chi-square test."
        ],
        correct: 0,
        explanation: "Survival was analyzed using Cox regression and Kaplan–Meier curves, as stated in the paper."
      },
      {
        question: "26. What does intention-to-treat analysis mean?",
        options: [
          "All randomized patients are analyzed in their original groups regardless of adherence.",
          "Only patients who complete treatment are included.",
          "Patients who drop out are removed from the analysis."
        ],
        correct: 0,
        explanation: "Intention-to-treat means analyzing patients as randomized. The paper uses an “intention-to-treat principle.”"
      },
      {
        question: "27. How were missing data handled?",
        options: [
          "Using pre-specified methods for missing or incomplete data.",
          "By excluding all patients with missing data.",
          "Missing data were ignored altogether."
        ],
        correct: 0,
        explanation: "The study employed pre-specified methods for missing data, as noted in the discussion of handling missing data."
      },
      {
        question: "28. Why are subgroup and sensitivity analyses important?",
        options: [
          "They assess the robustness of the results across different groups.",
          "They are only used to increase sample size.",
          "They replace the primary analysis if needed."
        ],
        correct: 0,
        explanation: "These analyses test consistency. The paper states they help evaluate the robustness of findings."
      },
      {
        question: "29. What does a two-sided type I error of 5% indicate?",
        options: [
          "A 5% risk of falsely rejecting the null hypothesis.",
          "A 5% chance of a false negative.",
          "It is used only for sample size calculation."
        ],
        correct: 0,
        explanation: "It indicates a 5% risk of a false-positive result. The design specified a two-sided type I error of 5%."
      },
      {
        question: "30. What is the role of the statistical analysis plan?",
        options: [
          "To predefine methods for data analysis and ensure proper interpretation.",
          "To determine the treatment allocation.",
          "To set the study budget."
        ],
        correct: 0,
        explanation: "The analysis plan predefines the methods. The paper instructs to “review the statistical methods used to compare groups.”"
      },
      {
        question: "31. What were the 3-year DFS rates found?",
        options: [
          "76% in both treatment arms.",
          "85% in one arm and 70% in the other.",
          "They varied widely between groups."
        ],
        correct: 0,
        explanation: "The trial reported 3-year DFS of 76% for both arms, as stated in the paper."
      },
      {
        question: "32. How were the baseline characteristics described?",
        options: [
          "They were well balanced between groups.",
          "They were notably different.",
          "They were not reported."
        ],
        correct: 0,
        explanation: "Baseline characteristics were well balanced, ensuring comparability, as noted in the paper."
      },
      {
        question: "33. Which group had a higher organ preservation rate?",
        options: [
          "The CRT-CNCT group.",
          "The INCT-CRT group.",
          "Both had the same rate."
        ],
        correct: 0,
        explanation: "The CRT-CNCT group achieved a higher organ preservation rate, per the paper’s findings."
      },
      {
        question: "34. What does local recurrence-free survival measure?",
        options: [
          "The time until the tumor recurs locally.",
          "The time until distant metastasis.",
          "Overall patient survival."
        ],
        correct: 0,
        explanation: "It measures the time until local recurrence, as illustrated by the Kaplan–Meier curves in the paper."
      },
      {
        question: "35. Why distinguish between statistical and clinical significance?",
        options: [
          "Because a statistically significant result may not be clinically meaningful.",
          "Because they are essentially identical.",
          "Because only one is considered in trial conclusions."
        ],
        correct: 0,
        explanation: "Statistical significance does not always equate to clinical importance, as contrasted in the paper."
      },
      {
        question: "36. Which bias was the trial keen to minimize?",
        options: [
          "Selection bias.",
          "Irrelevant measurement bias.",
          "Bias due to patient preference."
        ],
        correct: 0,
        explanation: "The trial aimed to minimize selection bias among others, as discussed in the paper."
      },
      {
        question: "37. Which tool is recommended for bias assessment?",
        options: [
          "The Cochrane Risk of Bias tool.",
          "A simple scoring system.",
          "The Kaplan–Meier method."
        ],
        correct: 0,
        explanation: "The paper recommends the Cochrane Risk of Bias tool (or Jadad score) for assessing bias."
      },
      {
        question: "38. How was performance bias addressed?",
        options: [
          "By using objective outcome assessments in a nonblinded design.",
          "By fully blinding all study personnel.",
          "Performance bias was not considered."
        ],
        correct: 0,
        explanation: "Objective outcome assessments help reduce performance bias, as noted in the paper’s discussion on blinding."
      },
      {
        question: "39. What enhances internal validity?",
        options: [
          "Robust randomization and allocation concealment.",
          "Including many study sites without standard protocols.",
          "Loose inclusion criteria."
        ],
        correct: 0,
        explanation: "Internal validity is enhanced by robust randomization and concealment, as emphasized in the paper."
      },
      {
        question: "40. Why is attrition bias important to consider?",
        options: [
          "Because dropouts can affect the reliability of the study’s findings.",
          "Because it only influences secondary outcomes.",
          "Because it is generally negligible."
        ],
        correct: 0,
        explanation: "Attrition bias can impact the reliability of results, as mentioned in the paper’s bias considerations."
      },
      {
        question: "41. What does external validity refer to?",
        options: [
          "The ability to generalize findings to other populations and settings.",
          "The consistency of the study’s internal methods.",
          "The precision of measurement tools."
        ],
        correct: 0,
        explanation: "External validity refers to how well results generalize, as discussed in the paper."
      },
      {
        question: "42. Which factor improves external validity?",
        options: [
          "Conducting the trial at multiple centers across varied populations.",
          "Limiting the study to a single specialized center.",
          "Using very strict inclusion criteria that limit diversity."
        ],
        correct: 0,
        explanation: "A multicenter approach improves generalizability, as the trial was conducted at “18 US institutions.”"
      },
      {
        question: "43. How does the trial compare its findings to previous evidence?",
        options: [
          "It compares results with historical controls and current literature.",
          "It does not reference previous studies.",
          "It only compares its internal subgroups."
        ],
        correct: 0,
        explanation: "The trial contextualizes its findings with historical data, as stated in the paper."
      },
      {
        question: "44. Why is generalizability important?",
        options: [
          "It determines if the results apply in real-world settings.",
          "It is only a theoretical concern.",
          "It has no impact on clinical practice."
        ],
        correct: 0,
        explanation: "Generalizability is crucial for applying findings broadly, as emphasized in the paper."
      },
      {
        question: "45. What is a major limitation mentioned?",
        options: [
          "The potential for tumor regrowth during the watch-and-wait period.",
          "An excessively large sample size.",
          "Significant imbalance in baseline characteristics."
        ],
        correct: 0,
        explanation: "A key limitation is the risk of tumor regrowth, with the paper noting a considerable percentage of regrowth."
      },
      {
        question: "46. How do limitations affect interpretation of results?",
        options: [
          "They provide context for potential confounders and uncertainties.",
          "They completely invalidate the findings.",
          "They are not relevant if the study is well-powered."
        ],
        correct: 0,
        explanation: "Limitations help frame the results, as noted by the paper’s discussion of confounders."
      },
      {
        question: "47. Which is considered a strength of the trial?",
        options: [
          "Its rigorous design and multicenter collaboration.",
          "Its limited geographical scope.",
          "The absence of detailed statistical analysis."
        ],
        correct: 0,
        explanation: "A major strength is its rigorous, multicenter design, as highlighted in the paper."
      },
      {
        question: "48. Why must confounders be considered?",
        options: [
          "They can bias the observed effects and lead to erroneous conclusions.",
          "They only affect laboratory experiments.",
          "They generally increase the sample size."
        ],
        correct: 0,
        explanation: "Confounders may distort results, as noted in the paper’s appraisal of potential biases."
      },
      {
        question: "49. What is a key clinical implication derived from the trial?",
        options: [
          "TNT with selective watch-and-wait may allow rectal preservation without compromising DFS.",
          "Surgery is mandatory for all patients regardless of response.",
          "Chemotherapy has little effect on rectal cancer outcomes."
        ],
        correct: 0,
        explanation: "The implication is that organ preservation is possible without compromising DFS, as stated in the paper."
      },
      {
        question: "50. How can these findings guide future research?",
        options: [
          "They encourage further investigation into nonoperative management and refining selection criteria.",
          "They indicate that no further research is necessary.",
          "They suggest that current treatment methods should be abandoned."
        ],
        correct: 0,
        explanation: "The findings prompt additional research in nonoperative management, as noted in the paper."
      }
    ];

    let currentQuestionIndex = 0;
    let score = 0;

    const questionContainer = document.getElementById('question-container');
    const submitButton = document.getElementById('submit-btn');
    const nextButton = document.getElementById('next-btn');
    const feedbackDiv = document.getElementById('feedback');
    const resultDiv = document.getElementById('result');
    const scoreSpan = document.getElementById('score');

    function showQuestion() {
      feedbackDiv.innerHTML = "";
      nextButton.classList.add('hidden');
      submitButton.classList.remove('hidden');

      const currentQuestion = questions[currentQuestionIndex];
      let html = `<h2>Question ${currentQuestionIndex + 1}:</h2>`;
      html += `<p>${currentQuestion.question}</p>`;
      html += '<ul class="options">';
      currentQuestion.options.forEach((option, index) => {
        html += `<li>
                  <label>
                    <input type="radio" name="option" value="${index}">
                    ${option}
                  </label>
                 </li>`;
      });
      html += '</ul>';
      questionContainer.innerHTML = html;
    }

    function showResult() {
      document.getElementById('quiz').classList.add('hidden');
      resultDiv.classList.remove('hidden');
      scoreSpan.textContent = score;
    }

    submitButton.addEventListener('click', function() {
      const options = document.getElementsByName('option');
      let selected = -1;
      for (const option of options) {
        if (option.checked) {
          selected = parseInt(option.value);
          break;
        }
      }
      if (selected === -1) {
        alert("Please select an answer!");
        return;
      }
      const currentQuestion = questions[currentQuestionIndex];
      if (selected === currentQuestion.correct) {
        feedbackDiv.innerHTML = "<span class='correct'>Correct!</span><br>" + currentQuestion.explanation;
        score += 1;
      } else {
        feedbackDiv.innerHTML = "<span class='incorrect'>Incorrect!</span><br>" + currentQuestion.explanation;
      }
      submitButton.classList.add('hidden');
      nextButton.classList.remove('hidden');
    });

    nextButton.addEventListener('click', function() {
      currentQuestionIndex++;
      if (currentQuestionIndex < questions.length) {
        showQuestion();
      } else {
        showResult();
      }
    });

    // Start the quiz
    showQuestion();
  </script>
</body>
</html>
